NCT00591149 2017-06-14Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerUniversity of Kansas Medical CenterPhase 2 Terminated16 enrolled 5 charts
NCT00485485 2012-08-07Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell CancerM.D. Anderson Cancer CenterPhase 2 Completed7 enrolled 7 charts